Showing results (561-570 of 1,594) with videos related to

Sort By:
Pageof 160
RSC Medicinal Chemistry|May 24, 2024
Antitubercular activity of 2-mercaptobenzothiazole derivatives targeting Mycobacterium tuberculosis type II NADH dehydrogenasePallavi Saha, Shashikanta Sau, Nitin Pal Kalia, et al.
RSC Medicinal Chemistry|May 24, 2024
Live cell screening to identify RNA-binding small molecule inhibitors of the pre-let-7-Lin28 RNA-protein interactionSydney L Rosenblum, Dalia M Soueid, George Giambasu, et al.
RSC Medicinal Chemistry|May 24, 2024
Anti-cancer activity and mechanism of flurbiprofen organoselenium compound RY-1-92 in non-small cell lung cancerBo Cui, Xianda Cheng, Xin Zhang, et al.
RSC Medicinal Chemistry|May 24, 2024
Correction: Aptamer AS1411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancerYuejie Zhu, Xiang Li, Qi Zhang, et al.
RSC Medicinal Chemistry|May 24, 2024
Chiral hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: the search for selective p53-activating agents for colorectal cancer therapyMees M Hendrikx, Adelino M R Pereira, Ana B Pereira, et al.
RSC Medicinal Chemistry|May 24, 2024
Design and synthesis of Meldrum's acid based 7-azaindole anchored 1,2,3-triazole hybrids as anticancer agentsMurali Krishna Vanga, Rambabu Bhukya, Vishnu Thumma, et al.
RSC Medicinal Chemistry|August 18, 2023
Design, synthesis, and evaluation of BTK-targeting PROTACs with optimized bioavailability in vitro and in vivoYonghui Sun, Zimo Yang, Zhimin Zhang, et al.
RSC Medicinal Chemistry|August 18, 2023
Inhibition of transcription and antiproliferative effects in a cancer cell line using antigene oligonucleotides containing artificial nucleoside analoguesLei Wang, Ryotaro Notomi, Shigeki Sasaki, et al.
RSC Medicinal Chemistry|August 18, 2023
N-Acylsulfonamide: a valuable moiety to design new sulfa drug analoguesRomain Amador, Ali Tahrioui, Magalie Barreau, et al.
RSC Medicinal Chemistry|October 20, 2023
Identification of novel 1,2,3-triazole isatin derivatives as potent SARS-CoV-2 3CLpro inhibitors via click-chemistry-based rapid screeningXiangyi Jiang, Jing Li, Antonio Viayna, et al.
Pageof 160